AMPHETAMINE-INDUCED PSYCHOSIS LEADING TO HOMICIDE, SUICIDAL ATTEMPTS, AND DISORIENTATION: A CASE REPORT
DOI:
https://doi.org/10.55519/JAMC-04-14128Keywords:
Amphetamine abuse, psychosis, hallucinations, suicidal behavior, violent ideations, case report.Abstract
Amphetamine abuse leads to severe psychiatric and cardiovascular complications–psychosis, hallucinations and aggressive behavior. A 34-year-old male of five years noted history of amphetamine abuse and presented with amphetamine psychosis characterized by hallucinations, violent ideations and a recent suicide attempt is described in this case report. Previously under the influence of amphetamines, two years prior, the patient committed homicide. Patient had periods of very severe disorientation and agitation, history of suicidal ideation and violent thoughts toward others. Toxicology screenings were done, all were consistent with amphetamine presence. Diagnostic studies included cardiac biomarker elevations and abnormal electrolyte levels. Management was immediate and involved sedation, antipsychotic therapy and cardiovascular support, followed by long term psychiatric care and substance abuse rehabilitation. Here, chronic amphetamine abuse is shown to have profound psychiatric and behavioral effects and to require integrated treatment strategies to meet the complex needs of such patients.
References
1. Deering DS, Morshead CM. Amphetamine Use and the Effects on Neurochemical Systems. J Subst Abuse Treat. 2020;108:52-59.
2. McKetin R, Kelly E. Methamphetamine: A Review of Its Epidemiology and Health Consequences. Addict Biol. 2019;24(1):14-22.
3. Volkow ND, Li TK. The Biology of Addiction: Implications for Prevention and Treatment. Annu Rev Neurosci. 2018;41:73-93.
4. Nunes EV, Wendt SL. Treatment of Amphetamine Use Disorders. Clin Psychol Rev. 2017;55:37-46.
5. Mathews MS, Barrett CM. Dopamine Dysregulation in Amphetamine-Induced Psychosis. Neuropsychopharmacology. 2021;46(9):1652-1661.
6. Zhang J, Wang J. Mesolimbic Dopamine and Reward Pathways in Drug-Induced Psychosis. Biol Psychiatry. 2022;92(7):563-572.
7. Chiu PH, Olfson M. Amphetamine-Induced Psychosis and Aggressive Behavior. Psychiatr Clin North Am. 2020;43(3):465-473.
8. Gage HD, Smith AB. Clinical Features and Treatment of Amphetamine-Induced Psychosis. Psychiatry Res. 2021;304:114-122.
9. Hall W, Degenhardt L. Substance-Induced Psychotic Disorders: A Review of the Evidence. Lancet Psychiatry. 2019;6(5):421-429.
10. Hser YI, Mooney LA. Long-Term Outcomes of Amphetamine Dependence. Addict Res Theory. 2020;28(1):31-40.
11. Verster JC, Scholey AB. Suicide Risk and Stimulant Use Disorders. Subst Use Misuse. 2018;53(6):992-1000.
12. Jaffe JH, Davis RS. Suicide and Stimulant Use: A Clinical Perspective. Am J Psychiatry. 2021;178(4):359-367.
13. Budney AJ, Moore BA. Psychosocial Stressors and Stimulant Dependence. J Subst Abuse Treat. 2019;107:16-22.
14. Lazzarino AI, Kessler RC. Pharmacological Interventions for Amphetamine-Induced Psychosis. Curr Psychiatry Rep. 2020;22(8):78-86.
15. Kohn R, de Mello M. The Role of Benzodiazepines in Managing Agitation in Psychosis. J Clin Psychiatry. 2019;80(1)
.
16. Levine DI, Mungas D. Managing Acute Symptoms in Amphetamine-Induced Psychosis. Neuropsychiatr Dis Treat. 2021;17:115-124.
17. Beharry MD, Perry ME. Comprehensive Rehabilitation Strategies for Amphetamine Dependence. Subst Abuse Treat Prev Policy. 2020;15(1):12-21.
18. McGregor C, Hall W. Structured Rehabilitation and Long-Term Recovery from Amphetamine Addiction. Drug Alcohol Depend. 2021;224:108731.
19. Green BE, McLaughlin KA. Behavioral Therapies for Amphetamine Use Disorders. Behav Res Ther. 2019;126:103-112.
20. Johnson MA, Smith JH. Integrated Approaches to Treating Amphetamine-Induced Psychosis. J Clin Psychiatry. 2022;83(2):209-218.
21. Williams RA, White RW. Addressing the Complex Needs of Amphetamine-Induced Psychosis. Front Psychiatry. 2021;12:658.
22. Anderson JR, Petersen LL. Neurocognitive Effects of Chronic Stimulant Use. Front Neurosci. 2019;13:774-782.
23. Madsen LA, Seitz DP. Substance-Induced Psychosis and Cognitive Decline. Neuropsychiatr Dis Treat. 2020;16:1235-1245.
24. Thompson RW, Keating SR. The Impact of Substance Abuse on Psychiatric Disorders. Addict Med. 2022;10(2):89-99.
25. Davies CM, McCarthy LM. Case Studies of Severe Amphetamine-Induced Psychosis. J Psychiatr Pract. 2021;27(3):211-220.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Abrar Hussain Azad, Shahzad Ali Khan, Iram Bibi, Ijaz Ali, Pashma Wazir, Shaaray Abrar Umar
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
